Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment his Department has made of the effect of the UK leaving Euratom on medical treatments provided by the NHS.

The Government considers the continuity of supply of medical radioisotopes as well as other medicines to be a high priority matter following the UK’s withdrawal from the EU. The Government has made clear that Euratom imposes no restrictions on the export of medical radioisotopes outside the EU. A cross-Departmental effort has already been underway since the summer of 2017 to coordinate and deliver a unified approach towards ensuring continuity of supply for medical radioisotopes after EU exit.